Trial
NCT06143423
A Clinical Trial of AP026 (TQA2226) for Injection in Adult Subjects.
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Collaborators
—
Condition
Diabetes Mellitus, Type 2
Intervention
AP026 (TQA2226) for injection
Why stopped
Study terminated for strategic business reasons.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-04-22